Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review
- PMID: 34607244
- DOI: 10.1016/j.ejmech.2021.113867
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review
Abstract
Imidazo[1,2-b]pyridazine scaffold represents an important class of heterocyclic nucleus which provides various bioactives molecules. Among them, the successful kinase inhibitor ponatinib led to a resurgence of interest in exploring new imidazo[1,2-b]pyridazine-containing derivatives for their putative therapeutic applications in medicine. This present review intends to provide a state-of-the-art of this framework in medicinal chemistry from 1966 to nowadays, unveiling different aspects of its structure-activity relationships (SAR). This extensive literature surveil may guide medicinal chemists for the quest of novel imidazo[1,2-b]pyridazine compounds with enhanced pharmacokinetics profile and efficiency.
Keywords: Anti-inflammatory; Antibacterial; Anticancer; Antiparasitic; Antiviral; Biological activities; Imidazo[1,2-b]pyridazine; Metabolic disorders; Radiotracers; Sleeping disorders; Structure-activity relationship; Thymic enhancers.
Copyright © 2021. Published by Elsevier Masson SAS.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous
